兽用疫苗佐剂市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

兽用疫苗佐剂市场按类型、给药途径、动物类型(家畜和伴侣动物)和地理细分。

市场快照

veterinary vaccine adjuvants market analysis
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.4 %
veterinary vaccine adjuvants market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

在预测期内,预计兽用疫苗佐剂市场的复合年增长率约为 6.4%。这个市场的增长是由于几个因素,例如疫苗中佐剂使用的增加、牲畜数量及其相关疾病的增加以及传染性人畜共患病的高发病率。根据疾病控制和预防中心 (CDC) 的数据,人畜共患病非常普遍,大约每四种新的或新出现的人类传染病中就有三种是由动物传播的,每 10 种已知的人类传染病中就有超过 6 种是由动物传播的。是从动物身上传播的。因此,对于上述传染性人畜共患病的治疗,使用了各种类型的疫苗。因此,

报告范围

疫苗佐剂是有助于增强疫苗免疫反应的物质。佐剂可以大致分为两种类型,第一种是疫苗递送系统,第二种是免疫刺激佐剂。

By Type
Alum and Calcium Salts
Oil Emulsion Adjuvants
Liposomes and Archaeosomes
Nanoparticles and Microparticles
Other Types
By Route of Administration
Oral
Subcutaneous
Intramuscular
Other Routes of Administration
By Animal Type
Livestock
Companion Animal
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

明矾和钙盐板块有望占据市场最大份额

80 多年来,铝基佐剂最常用于疫苗制剂。它们包括氢氧化铝和磷酸盐佐剂,以及磷酸钙佐剂。此外,这些佐剂的安全性极佳,副作用极少。然而,在少数情况下偶尔会出现一些过敏反应和肉芽肿。此外,最近的发展,例如在疫苗佐剂的配方中使用羟基氧化铝纳米粒子,在预防传染病和治疗各种疾病方面更有效。此外,用于开发和生产新疫苗的资金和投资不断增加,正在推动该领域的发展。

veterinary vaccine adjuvants market trends

预计北美将在预测期内做出重大贡献

在整个预测期内,预计北美将主导整个市场。这是由于越来越多地采用伴侣动物、增加宠物医疗保险以及改善兽医医疗保健基础设施。在北美地区,美国占有最大的市场份额。此外,随着美国人畜共患病的上升趋势,兽用疫苗的相关使用也在增加。因此,预计将在预测期内推动兽用疫苗佐剂市场的增长。

veterinary vaccine adjuvants market forecast

竞争格局

兽用疫苗佐剂市场竞争适度,由几个主要参与者组成。在市场份额方面,一些主要参与者目前主导着市场。随着动物传染病流行率的上升,预计未来几年很少有其他较小的参与者进入市场。该市场的一些主要参与者包括 SEPPIC、SPI Pharma、Brenntag Biosector AS、Bioveta AS 和 Zoetis 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Use of Adjuvants in Vaccine

      2. 4.2.2 Increase in Livestock Population and their Associated Diseases

      3. 4.2.3 High Incidence of Infectious Zoonotic Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Toxicity and Side Effects of Adjuvants

      2. 4.3.2 Stringent Regulatory Environment and Time-consuming Approvals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Alum and Calcium Salts

      2. 5.1.2 Oil Emulsion Adjuvants

      3. 5.1.3 Liposomes and Archaeosomes

      4. 5.1.4 Nanoparticles and Microparticles

      5. 5.1.5 Other Types

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Subcutaneous

      3. 5.2.3 Intramuscular

      4. 5.2.4 Other Routes of Administration

    3. 5.3 By Animal Type

      1. 5.3.1 Livestock

      2. 5.3.2 Companion Animal

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bioveta AS

      2. 6.1.2 Brenntag Biosector AS

      3. 6.1.3 Novavax

      4. 6.1.4 Phibro Animal Health Corporation

      5. 6.1.5 SEPPIC

      6. 6.1.6 SPI Pharma

      7. 6.1.7 Zoetis

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Veterinary Vaccine Adjuvants Market market is studied from 2018 - 2026.

The Veterinary Vaccine Adjuvants Market is growing at a CAGR of 6.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

SEPPIC, SPI Pharma, Brenntag Biosector AS, Bioveta AS, Novavax are the major companies operating in Veterinary Vaccine Adjuvants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!